Learn from Our Articles

The Victorian government has officially rejected all recommendations from the state’s inquiry into the legalisation and regulation of cannabis, marking a significant setback for reform advocates and signaling that Premier Jacinta Allan’s administration is prioritizing electoral caution over progressive drug

Australia’s medicinal cannabis market is booming — but much of the product fueling that growth is coming from overseas. In 2024 and 2025, imports from Canada surged nearly 75%, accounting for more than 80% of all cannabis entering Australia’s regulated

Australia’s medicinal cannabis sector has seen a dramatic surge in prescriptions, especially of high‑THC products, driven in large part by telehealth clinics and online “single‑issue” providers. But regulators warn this growth is not without cost: patient safety concerns, inadequate medical

Australia’s cannabis debate is entering a pivotal phase in 2025. The Greens have formally proposed a national framework for legalising recreational cannabis, while state-level movements — including a push within Victoria’s Liberal Party — show growing bipartisan interest in regulating

Australia’s medicinal cannabis industry, once hailed as a progressive step in healthcare innovation, is now under intense scrutiny. Regulators, doctors, and public health advocates are voicing growing concerns about over-prescription of high-THC cannabis products, potential misuse of regulatory loopholes, and

Australia’s medicinal cannabis industry is reaching a tipping point as domestic growers raise alarms over increasing reliance on imported products. Despite years of investment, local cultivators say burdensome regulations, high compliance costs, and slow government approvals have left them at

Australia’s booming medicinal cannabis sector is facing new questions about oversight after the Therapeutic Goods Administration (TGA) revealed it has not conducted safety investigations into the majority of unapproved cannabis products, despite receiving hundreds of adverse event reports from patients.

Patients prescribed medicinal cannabis in New South Wales (NSW) are at the center of a heated policy debate, as lawmakers push for reforms to driving laws that currently penalize them for testing positive for THC—even when they are not impaired.

Australia’s cannabis reform debate took a major step forward this week as the Penington Institute, a leading harm-reduction think tank, formally urged the legalisation of adult-use cannabis. Their message, delivered at the Medicinal Cannabis Industry Australia (MCIA) Conference, is clear:

Darwin has emerged as Australia’s unexpected capital for illicit drug consumption—including cannabis—according to the latest national wastewater analysis released today. The report, which examines drug residues flushed through sewage systems across the country, found the Northern Territory’s capital leading the

Tasmania’s cannabis sector is stepping into a new era of operational efficiency, compliance, and scalability, thanks to a fresh collaboration between Canadian software company Elevated Signals and Tasmanian cultivator Hale Farm. The partnership, announced this week, is poised to transform

Australia’s cannabis industry is today reflecting on the remarkable life and legacy of Dr. Teresa Towpik, who passed away this week after a long battle with cancer. As co-founder of Medihuanna and one of the country’s earliest and most outspoken